China’s Threat To Global Medtech Markets Is Rising
China’s economic might and industrial drive are being felt increasingly in medtech, and the just-released 14th five-year plan will give Chinese manufacturers more support for expansion, both at home and in overseas markets. Should EU and US industries be worried?
You may also be interested in...
China ambitiously wants to champion domestic medtech manufacturers in the global market. It also needs to ensure foreign manufacturers do not sustainably dominate its home market – while also benefiting from their technical expertise, for the time being at least. Against that backdrop, new Chinese data laws are being eyed by global medtechs with a certain trepidation.
The US listing of Chinese artificial intelligence, medical records and patient management system company Linkdoc could be derailed, after China issued new data review requirements tightening the oversight of overseas listings of domestic companies.
In this digest of Chinese medtech industry news, Omdia’s Sally Ye describes the new five-year medtech plan and other key information for the sector.